Page last updated: 2024-09-05

dibenzheptropine and Hepatitis E

dibenzheptropine has been researched along with Hepatitis E in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
de Man, RA; Donkers, JM; Li, P; Li, Y; Pan, Q; Peppelenbosch, MP; Qu, C; van de Graaf, SFJ; Yu, P	1

Other Studies

1 other study(ies) available for dibenzheptropine and Hepatitis E

Article	Year
FDA-drug screening identifies deptropine inhibiting hepatitis E virus involving the NF-κB-RIPK1-caspase axis. Antiviral research, 2019, Volume: 170 Topics: Antiviral Agents; Caspases; Cell Line, Tumor; Drug Evaluation, Preclinical; Hepatitis E; Hepatitis E virus; Hepatocytes; High-Throughput Screening Assays; Host Microbial Interactions; Humans; NF-kappa B; Receptor-Interacting Protein Serine-Threonine Kinases; Signal Transduction; Small Molecule Libraries; Tropanes; United States; United States Food and Drug Administration; Virus Replication	2019

Article

Year

FDA-drug screening identifies deptropine inhibiting hepatitis E virus involving the NF-κB-RIPK1-caspase axis.

Antiviral research, 2019, Volume: 170

Topics: Antiviral Agents; Caspases; Cell Line, Tumor; Drug Evaluation, Preclinical; Hepatitis E; Hepatitis E virus; Hepatocytes; High-Throughput Screening Assays; Host Microbial Interactions; Humans; NF-kappa B; Receptor-Interacting Protein Serine-Threonine Kinases; Signal Transduction; Small Molecule Libraries; Tropanes; United States; United States Food and Drug Administration; Virus Replication

2019